| 摘要 |
<p>Inhibitors of HCV replication of formula (I) the stereoisomers, prodrugs, tautomers, racemics, salts, hydrates or solvates thereof wherein R<SUP>1a</SUP>; R<SUP>1b</SUP> R<SUP>2</SUP>; R<SUP>3</SUP>; R<SUP>4a</SUP> and R<SUP>4b</SUP> have the meaning defined in the claims. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.</p> |
| 申请人 |
TIBOTEC PHARMACEUTICALS LTD.;RABOISSON, PIERRE JEAN-MARIE BERNARD;VANDYCK, KOEN;NYANGUILE, ORIGENE;MC GOWAN, DAVID CRAIG;VENDEVILLE, SANDRINE MARIE HELENE;AMSSOMS, KATIE INGRID EDUARD;BOUTTON, CARLO WILLY MAURICE;LORY, PEDRO MIGUEL JALES;HU, LILI;VAN DEN BROECK, WALTER MARCEL MATHILDE;CUMMINGS, MAXWELL DAVID;ROMBAUTS, KLARA;LAST, STEFAAN JULIEN;TAHRI, ABDELLAH |
发明人 |
RABOISSON, PIERRE JEAN-MARIE BERNARD;VANDYCK, KOEN;NYANGUILE, ORIGENE;MC GOWAN, DAVID CRAIG;VENDEVILLE, SANDRINE MARIE HELENE;AMSSOMS, KATIE INGRID EDUARD;BOUTTON, CARLO WILLY MAURICE;LORY, PEDRO MIGUEL JALES;HU, LILI;VAN DEN BROECK, WALTER MARCEL MATHILDE;CUMMINGS, MAXWELL DAVID;ROMBAUTS, KLARA;LAST, STEFAAN JULIEN;TAHRI, ABDELLAH |
